Children with Epicardial Pacemakers Face Risk of Cardiac Strangulation

An advisory notice has been issued in Canada for a rare, but potentially life-threatening risk of cardiac strangulation from epicardial pacemaker leads implanted in children, which may cause compression of the heart.

Health Canada issued an advisory on October 17, informing health care professionals and the public about the risk of epicardial pacemaker lead cardiac strangulation among children, stressing the importance of recognizing the symptoms of problems.

To date, there have been at least eight cases of cardiac strangulation reported by medical journals, including 2 deaths. Certain cases were recognized early enough that the children were successfully able to receive corrective surgery to replace the lead.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Epicardial pacemakers are connected to the heart through lead wires that monitor and correct a dysfunction in the heart’s firing mechanism. The problem arises from the epicardial lead, which can begin to compress the heart as the child grows. This may lead to strangulation of the heart.

Symptoms of potential heart compression from epicardial pacemaker leads may include chest pain, general fatigue, fainting, and signs of heart failure.

Health Canada indicated that children and parents of children known to have epicardial pacemaker leads should be aware of these symptoms, and contact their doctor if they notice any of them. If cardiac strangulation is diagnosed early, children are often able to undergo corrective surgery to replace the leads.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted 3 days ago)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.